Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub

In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.

While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

Novartis researchers aim to quash inflammation to treat chronic disease.

With Nerve Live, Novartis is harnessing the power of data for the benefit of patients.

Elyse Spatz Caplan’s cancer diagnosis impacted her life in more ways than 1

Jeff Weers’ passion inspired a new way of getting inhaled medicine past the body’s natural defenses to reach the lungs.